Angiotensin II-induced mesangial cell apoptosis: Role of oxidative stress

Molecular Medicine

Volumn 8, Issue 12, 2002, Pages 830-840

  Lodha, Saurabh ^b   Dani, Dhimant ^b   Mehta, Rajeev ^b   Bhaskaran, Madhu ^b   Reddy, Krishna ^b   Ding, Guohua ^b   Singhal, Pravin C ^a,b  

^a Ctr for Immunology and Inflammation   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ION; DNA FRAGMENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HEME OXYGENASE; HEMIN; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOLIPASE D; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL STIMULATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; MESANGIUM CELL; MOLECULAR DYNAMICS; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036997682     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402088     Document Type: Article

References (57)

1. Matsusaka T, Hymes J, Ichikawa I. (1996) Angiotensin in progressive renal diseases: theory and practice. J. Am. Soc. Nephrol. 7: 2025-2043.
2. Wolf G, Neilson EG. (1983) Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 3: 1531-1540.
3. Yoshida Y, Kawamura M, Ikomo A, et al. (1989) Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 36: 626-635.
4. Michael AF, Keane WF, Ralj L, et al. (1980) The glomerular mesangium. Kidney Int. 17: 141-154.
5. Pesce CM, Striker U, Peter E, et al. (1991) Glomerulosclerosis at both early and late stage is associated with cell turnover in mice transgenic for growth hormone. Lab. Invest. 65: 601-605.
6. Floege J, Burns MW, Alpers CF, et al. (1992) Glomerular cell proliferation and matrix synthesis. Kidney Int. 41: 297-309.
7. Fogo AB. (2001) progression and potential regression of glomerulosclerosis. Kidney Int. 59: 804-819.
8. Klahr S, Schreiner G, Ichikawa I. (1988) The progression of renal disease. N. Engl. J. Med. 318: 1657-1666.
9. Egido J. (1996) Vasoactive hormones and renal sclerosis. Kidney Int. 49: 578-598.
10. Border WA, Noble NA. (1998) Interaction of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 31: 181-188.
11. Anderson S, Meyer TW, Rennke HG, Brenner BM. (1985) Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 76: 612-619.
12. Kagami S, Border WA, Miller DE, Noble NA. (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93: 2431-2437.
13. Keane WF, Anderson S, Aurell M, et al. (1989) Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann. Intern. Med. 111: 503-516.
14. Taal MW, Brenner BM. (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 57: 1803-1817.
15. Dijkhorst-Oei LT, Stroes ES, Koomans HA, Rabelink TJ. (1999) Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J. Cardiovasc. Pharmacol. 33: 420-424.
16. Rajgopalan S, Kurz S, Munzel T, et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97: 1916-1923.
17. Sugiyama H, Kashihara N, Yamasaki Y, et al. (1994) Reactive oxygen species induce apoptosis in cultured mesangial cells. J. Am. Soc. Nephrol. 6: 796 (abstract).
18. Patel P, Varghese E, Ding G, et al. (2000) Transforming growth factor beta induces mesangial cell apoptosis through NO- and p53-dependent and -independent pathways. J. Investig. Med. 48: 403-410.
19. Sandau K, Pfeilschifter J, Brune B. (1997) Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 52: 378-386.
20. Harrison DJ. (1988) Cell death in the diseased glomerulus. Histopathology 12: 679-683.
21. Shimizu A, Kitamura H, Masuda Y, et al. (1995). Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 47: 114-121.
22. Baker AJ, Mooney A, Hughes J, et al. (1994) Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94: 2105-2116.
23. Okuda S, Languino LR, Ruoslahti E, Border WA. (1990). Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. J. Clin. Invest. 86: 453-462.
24. Yamamoto T, Noble NA, Miller DE, Border WA. (1994) Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 45: 916-927.
25. Sugiyama H, Kashihara N, Makino H, et al. (1996) Apoptosis in glomerular sclerosis. Kidney Int. 49: 103-111.
26. Hattori T, Shindo S, Kawamura H. (1998) Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model. Nephron 79: 186-191.
27. Zhang W, Khanna P, Chan LL, et al. (1997) Diabetes-induced apoptosis in rat kidney. Biochem. Mol. Med. 61: 58-62.
28. Cao Z, Kelly DJ, Cox A, et al. (2000) Angiotensin type2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int. 58: 2437-2451.
29. Kajstura J, Cigola E, Malhotra A, et al. (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell Cardiol. 29: 859-870.
30. Wang R, Zagariya A, Ibarra-sunga O, et al. (1999) Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am. J. Physiol. 276: L885-L889.
31. Yamada T, Akishhita M, Pollman MJ, et al. (1998) Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study. Life Sci. 63: 289-295.
32. Yamada T, Horiuchi M, Dzau VJ. (1996) Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. 93: 156-160.
33. Ding G, Reddy K, Kapasi AA, et al. (2002) Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am. J. Physiol. 283: F173-F180.
34. Reddy K, Ding G, Bhasakaran M, et al. (2000) ANG II-induced proximal tubular cell apoptosis is mediated through TGF-β, Fas, FasL, and altered ratio of BCL-2/Bax. J. Am. Soc. Nephrol. 11: 463 (abstract).
35. Ray PE, Bruggeman LA, Horikoshi S, et al. (1994). Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 45: 177-184.
36. Mei X, Gao C, Cui R. (2001) The role of AT1 receptor and cyclin kinase inhibitor p27 protein in angiotensin II-induced hypertrophy of mesangial cell. Chinese J. Int. Med. 40: 609-612.
37. Ardaillou R. (1999) Angiotensin II receptors. J. Am. Soc. Nephrol. 10: S30-S39.
38. Singhal PC, Scharschmidt LA, Gibbons N, Hays RM. (1987) Mesangial cell contraction and relaxation on silicone rubber surface. Kidney Int. 30: 862-873.
39. Singhal PC, Ding G, DeCandido S, et al. (1987) Endocytosis by cultured mesangial cells and associated changes in prostaglandin synthesis. Am. J. Physiol. 252: F627-F634.
40. 2 and platelet activating factor formation by cultured mesangial cells. J. Clin. Invest. 28: 936-944.
41. Singhal PC, Gibbons N, Franki N, et al. (1998) Simulated glomerular hypertension promotes mesangial all apoptosis ad expression of cathepsin-B and SEP-2. J. Invest. Med. 46: 42-50.
42. Herrmann H, Lorenz HM, Voll R, et al. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22: 5506-5507.
43. Balla G, Jacob HS, Balla J, et al. (1992) Ferritin: a cytoprotective antioxidant stratagem of endothelium. J. Biol. Chem. 267: 18148-18153.
44. Lassegue B, Alexander RW, Clark M, et al. (1993) Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulate vascular smooth muscle cells. Biochem. J. 292: 509-517.
45. Pappu AS, Hauser G. (1983) Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase. Neurochem. Res. 8: 1565-1575.
46. Foidart J, Sraer J, Delarue F, et al. (1980) Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility. FEBS Lett. 121: 333-339.
47. Lapinski R, Perico N, Remuzzi A, et al. (1996) Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J. Am. Soc. Nephrol. 7: 653-660.
48. Arai M, Wada A, Isaka Y, et al. (1995) In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem. Biophys. Res. Commun. 206: 525-532.
49. Shankland SJ, Wolf G. (2000). Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. 278: F515-F529.
50. Dimmeler S, Rippmann V, Weiland U, et al. (1997) Angiotensin II induces apoptosis of human endothelial cells: protective effect of nitric oxide. Circ. Res. 81: 970-976.
51. 2+ signals. Kidney Int. 58: 1870-1884.
52. Higashi Y, Sasaki S, Nagakawa K, et al. (2002). Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346: 1954-1962.
53. Griendling KK, Minieri CA, Ollerenshaw D, Alexander RW. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74: 1141-1148.
54. Mollanau H, Wendt M, Szocs K, et al. (2002) Effects of angiotensin infusion on the expression and function of NAD (P) H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90: E58-E65.
55. Irani K. (2000) Oxidant signaling in vascular cell growth, death and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87: 179-183.
56. Paller MS, Weber K, Patten M. (1998) Nitric oxide-mediated renal epithelial cell injury during hypoxia and reoxygenation. Renal Fail. 20: 459-469.
57. Bank N, Kiroycheva M, Singhal PC, et al. (2000) Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int. 58: 62-89.